These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 12432296)

  • 1. Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study.
    Vuong T; Belliveau PJ; Michel RP; Moftah BA; Parent J; Trudel JL; Reinhold C; Souhami L
    Dis Colon Rectum; 2002 Nov; 45(11):1486-93; discussion 1493-5. PubMed ID: 12432296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Pathologic Response of T3 Rectal Cancer to High-Dose-Rate Endorectal Brachytherapy Comparable to External Beam Radiotherapy?
    Garfinkle R; Lachance S; Vuong T; Mikhail A; Pelsser V; Gologan A; Morin NA; Vasilevsky CA; Boutros M
    Dis Colon Rectum; 2019 Mar; 62(3):294-301. PubMed ID: 30741768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: technical aspects.
    Vuong T; Devic S; Moftah B; Evans M; Podgorsak EB
    Brachytherapy; 2005; 4(3):230-5. PubMed ID: 16182224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting residual rectal adenocarcinoma in the surgical specimen after preoperative brachytherapy with endoscopic ultrasound.
    Romagnuolo J; Parent J; Vuong T; Bélanger M; Michel RP; Belliveau PJ; Trudel JL
    Can J Gastroenterol; 2004 Jul; 18(7):435-40. PubMed ID: 15229745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation.
    Valentini V; Coco C; Cellini N; Picciocchi A; Genovesi D; Mantini G; Barbaro B; Cogliandolo S; Mattana C; Ambesi-Impiombato F; Tedesco M; Cosimelli M
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1067-75. PubMed ID: 9539561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
    Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
    Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
    Klenova A; Parvanova V; Georgiev R; Gesheva N
    J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost.
    Jakobsen A; Mortensen JP; Bisgaard C; Lindebjerg J; Hansen JW; Rafaelsen SR
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):461-5. PubMed ID: 16226396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
    Tjandra JJ; Reading DM; McLachlan SA; Gunn IF; Green MD; McLaughlin SJ; Millar JL; Pedersen JS
    Dis Colon Rectum; 2001 Aug; 44(8):1113-22. PubMed ID: 11535850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group.
    Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; MacKay JR; Joseph D; Bell A; Goldstein D
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):883-7. PubMed ID: 11429215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate endorectal brachytherapy for locally advanced rectal cancer in previously irradiated patients.
    Chuong MD; Fernandez DC; Shridhar R; Hoffe SE; Saini A; Hunt D; Meredith KL; Biagioli MC
    Brachytherapy; 2013; 12(5):457-62. PubMed ID: 23707855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer.
    Kaminsky-Forrett MC; Conroy T; Luporsi E; Peiffert D; Lapeyre M; Boissel P; Guillemin F; Bey P
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):935-41. PubMed ID: 9869213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.
    Rullier E; Goffre B; Bonnel C; Zerbib F; Caudry M; Saric J
    Ann Surg; 2001 Nov; 234(5):633-40. PubMed ID: 11685026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.
    Theodoropoulos G; Wise WE; Padmanabhan A; Kerner BA; Taylor CW; Aguilar PS; Khanduja KS
    Dis Colon Rectum; 2002 Jul; 45(7):895-903. PubMed ID: 12130878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated radiotherapy for locally advanced rectal cancers: a phase I-II trial.
    Allal AS; Bieri S; Bründler MA; Soravia C; Gertsch P; Bernier J; Morel P; Roth AD
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1076-81. PubMed ID: 12419434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer.
    Mehta VK; Poen J; Ford J; Edelstein PS; Vierra M; Bastidas AJ; Young H; Fisher G
    Dis Colon Rectum; 2001 Jan; 44(1):52-8. PubMed ID: 11805563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.